Alpha-Synuclein Effects on Mitochondrial Quality Control in Parkinson’s Disease
Author Information
Author(s): Shen Lydia, Dettmer Ulf
Primary Institution: Cornell University
Hypothesis
How does alpha-synuclein influence mitochondrial maintenance in Parkinson's disease?
Conclusion
The study reviews the relationship between alpha-synuclein and mitochondrial quality control pathways in Parkinson's disease, highlighting its potential role in mitochondrial dysfunction.
Supporting Evidence
- Alpha-synuclein is implicated in the formation of Lewy bodies, a hallmark of Parkinson's disease.
- Mitochondrial dysfunction is linked to the pathogenesis of Parkinson's disease.
- Impaired mitochondrial quality control may contribute to neuronal death in Parkinson's disease.
- Recent studies suggest that alpha-synuclein may affect mitochondrial biogenesis and dynamics.
Takeaway
This study looks at how a protein called alpha-synuclein affects the health of mitochondria, which are important for brain cells, in people with Parkinson's disease.
Methodology
The review summarizes recent findings regarding alpha-synuclein's effects on mitochondrial biogenesis, dynamics, and autophagy.
Limitations
The precise mechanisms linking alpha-synuclein with mitochondrial quality control are not fully understood.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website